Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (211-220 of 341) with videos related to

Pageof 35
Sort By:
BMC Nephrology|August 7, 2024
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)Lisa C Willcocks, Wendi Qian, Ruzaika Cader, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2023
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitisBeatriz Sánchez Álamo, Laura Moi, Ingeborg Bajema, et al.
Kidney International|March 20, 2023
Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitisNicolas Benichou, Pierre Charles, Benjamin Terrier, et al.
The Lancet. Gastroenterology & Hepatology|March 23, 2026
Indocyanine green fluorescence angiography for anastomotic perfusion assessment in colorectal surgery: a systematic review with meta-analysis, meta-regression, and trial sequential analysesÉanna J Ryan, Odhrán K Ryan, Neil Corrigan, et al.
Seminars in Arthritis and Rheumatism|November 1, 2020
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature reviewSara Monti, Kaitlin A Quinn, Robin Christensen, et al.
Annals of the Rheumatic Diseases|February 11, 2022
Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritisDavid Jayne, Brad Rovin, Eduardo F Mysler, et al.
Journal of Neurology|December 20, 2022
Diagnosis and management of adult primary angiitis of the central nervous system: an international survey on current practicesAhmad Nehme, Sylvain Lanthier, Marion Boulanger, et al.
The New England Journal of Medicine|November 18, 2011
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritisMary Anne Dooley, David Jayne, Ellen M Ginzler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide studyKarl Emil Nelveg-Kristensen, Wladimir Szpirt, Nicholas Carlson, et al.
Annals of the Rheumatic Diseases|August 30, 2011
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosusGabor G Illei, Ricard Cervera, Richard K Burt, et al.
Pageof 35

Showing results (211-220 of 341) with videos related to

Sort By:
Pageof 35
BMC Nephrology|August 7, 2024
A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING)Lisa C Willcocks, Wendi Qian, Ruzaika Cader, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2023
Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitisBeatriz Sánchez Álamo, Laura Moi, Ingeborg Bajema, et al.
Kidney International|March 20, 2023
Proteinuria and hematuria after remission induction are associated with outcome in ANCA-associated vasculitisNicolas Benichou, Pierre Charles, Benjamin Terrier, et al.
The Lancet. Gastroenterology & Hepatology|March 23, 2026
Indocyanine green fluorescence angiography for anastomotic perfusion assessment in colorectal surgery: a systematic review with meta-analysis, meta-regression, and trial sequential analysesÉanna J Ryan, Odhrán K Ryan, Neil Corrigan, et al.
Seminars in Arthritis and Rheumatism|November 1, 2020
Use and reporting of outcome measures in randomized trials for anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic literature reviewSara Monti, Kaitlin A Quinn, Robin Christensen, et al.
Annals of the Rheumatic Diseases|February 11, 2022
Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritisDavid Jayne, Brad Rovin, Eduardo F Mysler, et al.
Journal of Neurology|December 20, 2022
Diagnosis and management of adult primary angiitis of the central nervous system: an international survey on current practicesAhmad Nehme, Sylvain Lanthier, Marion Boulanger, et al.
The New England Journal of Medicine|November 18, 2011
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritisMary Anne Dooley, David Jayne, Ellen M Ginzler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide studyKarl Emil Nelveg-Kristensen, Wladimir Szpirt, Nicholas Carlson, et al.
Annals of the Rheumatic Diseases|August 30, 2011
Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosusGabor G Illei, Ricard Cervera, Richard K Burt, et al.
Pageof 35